Eris Lifesciences to acquire remaining 30% stake in Swiss Parenterals

Eris Lifesciences agreed to acquire the balance 30% stake in Swiss Parenterals for ₹423.3 crore via a share swap, making it a wholly-owned subsidiary. The deal is expected to close before March 31, 2026.

“This acquisition will strengthen operational control, improving overall cost efficiencies and enabling full financial consolidation.”indiainfoline.com

• 1 source
• indiainfoline.comEris Lifesciences to acquire balance 30% stake in Swiss Parenterals | India InfolineNov 25, 2025

Summarized from public sources; check the original articles before acting on it.